23andMe sold to Big Pharma: Biotech firm Regeneron has agreed to purchase 23andMe out of bankruptcy for the low low price of just $256 million! That’s quite a tumble for the once white-hot DNA testing startup that was valued at $6 billion in 2021. It also raises a host of privacy concerns, as a Big Pharma company will take possession of the genetic samples and data of millions of former 23andMe customers. They’ve promised to abide by 23andMe’s safety and privacy policies but… that definitely leaves some wiggle room! 

 #Biohackers Connect  
 #Digital Wellness 📱🧘 


https://www.wsj.com/tech/biotech/regeneron-to-buy-23andme-out-of-bankruptcy-for-256-million-a1f27eff?st=pbrXBx&reflink=desktopwebshare_permalink&_bhlid=3f7a790c7a17bbbc637b226b4914308dd9fb5561

Regeneron to Buy 23andMe Out of Bankruptcy for $256 Million

Biohackers Connect

Digital Wellness 📱🧘

23andMe sold to Big Pharma: Biotech firm Regeneron has agreed to purchase 23andMe out of bankruptcy for the low low price of just $256 million! That’s quite a tumble for the once white-hot DNA testing startup that was valued at $6 billion in 2021. It also raises a host of privacy concerns, as a Big Pharma company will take possession of the genetic samples and data of millions of former 23andMe customers. They’ve promised to abide by 23andMe’s safety and privacy policies but… that definitely leaves some wiggle room!    #Biohackers Connect    #Digital Wellness 📱🧘    https://www.wsj.com/tech/biotech/regeneron-to-buy-23andme-out-of-bankruptcy-for-256-million-a1f27eff?st=pbrXBx&reflink=desktopwebshare_permalink&_bhlid=3f7a790c7a17bbbc637b226b4914308dd9fb5561

Tasia

A group of likeminded people in Biohackers Connect are talking about this.